Buchumschlag

Combining Percentage Prostate‐Specific Antigen Reduction and Multiparametric Magnetic Resonance Imaging to Reduce Unnecessary Biopsy After Focal Therapy With High‐Intensity Focused Ultrasound for Prostate Cancer

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Po‐Fan Hsieh, Jun Naruse, Soichiro Yuzuriha, Tatsuya Umemoto, Chi‐Ping Huang, Sunao Shoji
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	International Journal of Urology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Editorial Comment to “Combining Percentage Prostate‐Specific Antigen Reduction and Multiparametric Magnetic Resonance Imaging to Reduce Unnecessary Biopsy After Focal Therapy With High‐Intensity Focused Ultrasound for Prostate Cancer”
von: Yoh Matsuoka
Veröffentlicht: (2025)

Frontiers of Ultrasound Technology in Prostate Cancer Treatment
von: Sunao Shoji, et al.
Veröffentlicht: (2025)

Editorial Comments to Impact of Approach Routes in MRI ‐Ultrasound Fusion Prostate Biopsy on Post‐Biopsy Complications: A Propensity Score‐Matched Analysis
von: Sunao Shoji
Veröffentlicht: (2025)

Intraperitoneal Bleeding After Ultrasound‐Guided Transperineal Prostate Biopsy
von: Lisa Chapman, et al.
Veröffentlicht: (2024)

Editorial Comment on Beyond Total PSA : Clinical Significance of S2 , 3PSA % in Reducing Unnecessary Prostate Biopsies
von: Yusuke Goto
Veröffentlicht: (2026)

External Validation on a Japanese Cohort of a Computer‐Aided Diagnosis System Aimed at Characterizing ISUP ≥ 2 Prostate Cancers at Multiparametric MRI
von: Raphael Escande, et al.
Veröffentlicht: (2025)

Impact of Approach Routes in MRI –Ultrasound Fusion Prostate Biopsy on Post‐Biopsy Complications: A Propensity Score‐Matched Analysis
von: Hiroki Tanaka, et al.
Veröffentlicht: (2025)

Editorial Comment on “The Evolution of Prostate Multiparametric MRI and Its Application in Prostate Cancer Clinical Management”
von: Yoshiko Ueno
Veröffentlicht: (2026)

Prostate‐Specific Antigen Density as a Predictor of Biochemical Failure Among Prostate Cancer Patients Who Underwent Open Radical Prostatectomy
von: Edel Rafael Rodea-Montero, et al.
Veröffentlicht: (2026)

Utility of Combining Prostate Health Index and Magnetic Resonance Imaging for the Diagnosis of Prostate Cancer
von: Yoshitaka Sekine, et al.
Veröffentlicht: (2025)

Time to Prostate‐Specific Antigen Failure as a Unique Prognosticator of Overall Survival in Biochemically Recurrent Prostate Cancer Patients Undergoing Radical Prostatectomy
von: Tomoyuki Shimabukuro, et al.
Veröffentlicht: (2025)

Editorial Comment to Histological parameters and stromal desmoplastic status affecting accurate diagnosis of extraprostatic extension of prostate cancer using multi‐parametric magnetic resonance imaging
von: Sunao Shoji
Veröffentlicht: (2024)

Hemorrhagic Risk of Transrectal Ultrasound‐Guided Prostate Biopsy Under Continued Antithrombotic Therapy
von: Naoki Akagi, et al.
Veröffentlicht: (2026)

Editorial Comment: Prostate‐Specific Antigen Dynamics and Bone Predominance as Predictors of Efficacy in Radium‐223 Treatment for Castration‐Resistant Prostate Cancer
von: Ammar Alanbuki
Veröffentlicht: (2025)

Considerations on the Optimal Imaging for Prostate Cancer Diagnosis
von: Fumihiko Urabe, et al.
Veröffentlicht: (2025)

Clinical Predictors of Fluoroquinolone‐Resistant Escherichia coli in Transrectal Ultrasound‐Guided Prostate Biopsy: Insights for Tailored Prophylaxis
von: Takatoshi Somoto, et al.
Veröffentlicht: (2025)

Local Anesthetic Transperineal Prostate Biopsy: Does It Affect Uroflowmetry Results
von: İsa Dağlı, et al.
Veröffentlicht: (2026)

Is Docetaxel Essential for Darolutamide‐Based Metastatic Hormone‐Sensitive Prostate Cancer Therapy?
von: Wei Chen, et al.
Veröffentlicht: (2025)

Editorial Comment on Impact of Approach Routes in MRI ‐Ultrasound Fusion Prostate Biopsy on Postbiopsy Complications: A Propensity Score‐Matched Analysis
von: Fumihiko Urabe
Veröffentlicht: (2025)

Editorial Comment on "Frontiers of Ultrasound Technology in Prostate Cancer Treatment"
von: Hiroshi Hirata
Veröffentlicht: (2025)

Active Surveillance in Prostate Cancer With Intermediate‐Risk Features: The PRIAS‐JAPAN Study
von: Leandro Blas, et al.
Veröffentlicht: (2025)

Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin
von: Ahmet Yıldırım Balık, et al.
Veröffentlicht: (2026)

Shifts in Diagnostic Approaches for Prostate Cancer: Impact of MRI ‐Informed Biopsies on Low‐Risk Cancer Detection
von: Yoichiro Tohi, et al.
Veröffentlicht: (2025)

Editorial Comment on Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin
von: Takanori Sekito, et al.
Veröffentlicht: (2026)

Outcomes and Safety Profile of Repeated Progressive Site‐Directed Therapy for Patients With Oligometastatic Castration‐Resistant Prostate Cancer
von: Yosuke Yasuda, et al.
Veröffentlicht: (2025)

Real‐World Outcomes of Combination Therapy With Radium‐223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration‐Resistant Prostate Cancer
von: Kenichi Hata, et al.
Veröffentlicht: (2026)

Risk Model for Lymph Node‐Positive Prostate Cancer After Radical Prostatectomy
von: Kojiro Tashiro, et al.
Veröffentlicht: (2025)

Editorial Comment Regarding “Shifts in Diagnostic Approaches for Prostate Cancer: Impact of MRI ‐Informed Biopsies on Low‐Risk Cancer Detection”
von: Makoto Kawase
Veröffentlicht: (2025)

Indirect Comparison of PROpel and TALAPRO ‐2 Trials Using the Shiny Method: A Comparative Analysis in Metastatic Castration‐Resistant Prostate Cancer
von: Yosuke Yasuda, et al.
Veröffentlicht: (2025)

Advanced Urology, HoLEP Laser Prostate Surgery, Penile Implant & Kidney Stone Treatment in Jordan – Dr. Amjad Al-Maslamani
von: Almuslamani, Amjad
Veröffentlicht: (2025)

Comorbid Diabetes Mellitus Contributes to Residual Overactive Bladder After Transurethral Surgery for Benign Prostatic Hyperplasia
von: Koji Miki, et al.
Veröffentlicht: (2025)

Transcatheter Arterial Embolization Combined With Systemic Therapy for Metastatic Hormone–Sensitive Prostate Cancer Presenting as a Giant Pelvic Mass
von: Zhipeng Yan, et al.
Veröffentlicht: (2026)

Prostate cancer in a nutshell
von: Mike Kirby
Veröffentlicht: (2024)

Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone‐Sensitive Prostate Cancer: YUSHIMA Study
von: Yosuke Yasuda, et al.
Veröffentlicht: (2025)

Harnessing the Power of Data to Improve Prostate Cancer Pathways: The South West Prostate Cancer Dashboard
von: Mini Sardar, et al.
Veröffentlicht: (2026)

To Investigate Disparities in Strategies for Low‐Risk Prostate Cancer by Facility Type Using the Japan Study Group of Prostate Cancer Database
von: Satoshi Kobayashi, et al.
Veröffentlicht: (2026)

Reduced Uncoupling Protein 1 Expression in Periprostatic Adipose Tissue and Its Association With Higher Prostate Cancer Grade
von: Eiji Kashiwagi, et al.
Veröffentlicht: (2026)

Gleason Regrading After Prostatectomy—Results From the Irish Prostate Cancer Outcome Research ( IPCOR ) Situated in the International Context
von: Noa Gordon, et al.
Veröffentlicht: (2026)

Solitary Testicular Metastasis From Ductal Prostate Cancer 5 Years After Radical Prostatectomy: A Case Report
von: Martina Romani, et al.
Veröffentlicht: (2026)

Prostate cancer and liquid biopsies: Clinical applications and challenges
von: Fumihiko Urabe, et al.
Veröffentlicht: (2024)